Development and Clinical Applications of a Virtual Imaging Framework for Optimizing Photon-counting CT

Toward widespread use of virtual trials in medical imaging innovation and regulatory science

The rapid advancement in the field of medical imaging presents a challenge in keeping up to date with the necessary objective evaluations and optimizations for safe and effective use in clinical settings. These evaluations are traditionally done using clinical imaging trials, which while effective, pose several limitations including high costs, ethical considerations for repetitive experiments, time constraints, and lack of ground truth. To tackle these issues, virtual trials (aka in silico trials) have emerged as a promising alternative, using computational models of human subjects and imaging devices, and observer models/analysis to carry out experiments. To facilitate the widespread use of virtual trials within the medical imaging research community, a major need is to establish a common consensus framework that all can use. Based on the ongoing efforts of an AAPM Task Group (TG387), this article provides a comprehensive overview of the requirements for establishing virtual imaging trial frameworks, paving the way toward their widespread use within the medical imaging research community. These requirements include credibility, reproducibility, and accessibility. Credibility assessment involves verification, validation, uncertainty quantification, and sensitivity analysis, ensuring the accuracy and realism of computational models. A proper credibility assessment requires a clear context of use and the questions that the study is intended to objectively answer. For reproducibility and accessibility, this article highlights the need for detailed documentation, user-friendly software packages, and standard input/output formats. Challenges in data and software sharing, including proprietary data and inconsistent file formats, are discussed. Recommended solutions to enhance accessibility include containerized environments and data-sharing hubs, along with following standards such as CDISC (Clinical Data Interchange Standards Consortium). By addressing challenges associated with credibility, reproducibility, and accessibility, virtual imaging trials can be positioned as a powerful and inclusive resource, advancing medical imaging innovation and regulatory science.

Photon-counting computed tomography versus energy-integrating computed tomography for detection of small liver lesions: comparison using a virtual framework imaging

Purpose

Photon-counting computed tomography (PCCT) has the potential to provide superior image quality to energy-integrating CT (EICT). We objectively compare PCCT to EICT for liver lesion detection.

Approach

Fifty anthropomorphic, computational phantoms with inserted liver lesions were generated. Contrast-enhanced scans of each phantom were simulated at the portal venous phase. The acquisitions were done using DukeSim, a validated CT simulation platform. Scans were simulated at two dose levels (CTDI vol 1.5 to 6.0 mGy) modeling PCCT (NAEOTOM Alpha, Siemens, Erlangen, Germany) and EICT (SOMATOM Flash, Siemens). Images were reconstructed with varying levels of kernel sharpness (soft, medium, sharp). To provide a quantitative estimate of image quality, the modulation transfer function (MTF), frequency at 50% of the MTF (f 50 ), noise magnitude, contrast-to-noise ratio (CNR, per lesion), and detectability index (d ' , per lesion) were measured.

Results

Across all studied conditions, the best detection performance, measured byd ' , was for PCCT images with the highest dose level and softest kernel. With soft kernel reconstruction, PCCT demonstrated improved lesion CNR andd ' compared with EICT, with a mean increase in CNR of 35.0% ( p < 0.001 ) and 21% ( p < 0.001 ) and a mean increase ind ' of 41.0% ( p < 0.001 ) and 23.3% ( p = 0.007 ) for the 1.5 and 6.0 mGy acquisitions, respectively. The improvements were greatest for larger phantoms, low-contrast lesions, and low-dose scans.

Conclusions

PCCT demonstrated objective improvement in liver lesion detection and image quality metrics compared with EICT. These advances may lead to earlier and more accurate liver lesion detection, thus improving patient care.

A systematic assessment and optimization of photon-counting CT for lung density quantifications

BACKGROUND

Photon-counting computed tomography (PCCT) has recently emerged into clinical use; however, its optimum imaging protocols and added benefits remains unknown in terms of providing more accurate lung density quantification compared to energy-integrating computed tomography (EICT) scanners.

PURPOSE

To systematically assess the performance of a clinical PCCT scanner for lung density quantifications and compare it against EICT.

METHODS

This cross-sectional study involved a retrospective analysis of subjects scanned (August-December 2021) using a clinical PCCT system. The influence of altering reconstruction parameters was studied (reconstruction kernel, pixel size, slice thickness). A virtual CT dataset of anthropomorphic virtual subjects was acquired to demonstrate the correspondence of findings to clinical dataset, and to perform systematic imaging experiments, not possible using human subjects. The virtual subjects were imaged using a validated, scanner-specific CT simulator of a PCCT and two EICT (defined as EICT A and B) scanners. The images were evaluated using mean absolute error (MAE) of lung and emphysema density against their corresponding ground truth.

RESULTS

Clinical and virtual PCCT datasets showed similar trends, with sharper kernels and smaller voxel sizes increasing percentage of low-attenuation areas below -950 HU (LAA-950) by up to 15.7 ± 6.9% and 11.8 ± 5.5%, respectively. Under the conditions studied, higher doses, thinner slices, smaller pixel sizes, iterative reconstructions, and quantitative kernels with medium sharpness resulted in lower lung MAE values. While using these settings for PCCT, changes in the dose level (13 to 1.3 mGy), slice thickness (0.4 to 1.5 mm), pixel size (0.49 to 0.98 mm), reconstruction technique (70 keV-VMI to wFBP), and kernel (Qr48 to Qr60) increased lung MAE by 15.3 ± 2.0, 1.4 ± 0.6, 2.2 ± 0.3, 4.2 ± 0.8, and 9.1 ± 1.6 HU, respectively. At the optimum settings identified per scanner, PCCT images exhibited lower lung and emphysema MAE than those of EICT scanners (by 2.6 ± 1.0 and 9.6 ± 3.4 HU, compared to EICT A, and by 4.8 ± 0.8 and 7.4 ± 2.3 HU, compared to EICT B). The accuracy of lung density measurements was correlated with subjects' mean lung density (p < 0.05), measured by PCCT at optimum setting under the conditions studied.

CONCLUSION

Photon-counting CT demonstrated superior performance in density quantifications, with its influences of imaging parameters in line with energy-integrating CT scanners. The technology offers improvement in lung quantifications, thus demonstrating potential toward more objective assessment of respiratory conditions.

Development of physiologically-informed computational coronary artery plaques for use in virtual imaging trials

BACKGROUND

As a leading cause of death, worldwide, cardiovascular disease is of great clinical importance. Among cardiovascular diseases, coronary artery disease (CAD) is a key contributor, and it is the attributed cause of death for 10% of all deaths annually. The prevalence of CAD is commensurate with the rise in new medical imaging technologies intended to aid in its diagnosis and treatment. The necessary clinical trials required to validate and optimize these technologies require a large cohort of carefully controlled patients, considerable time to complete, and can be prohibitively expensive. A safer, faster, less expensive alternative is using virtual imaging trials (VITs), utilizing virtual patients or phantoms combined with accurate computer models of imaging devices.

PURPOSE

In this work, we develop realistic, physiologically-informed models for coronary plaques for application in cardiac imaging VITs.

METHODS

Histology images of plaques at micron-level resolution were used to train a deep convolutional generative adversarial network (DC-GAN) to create a library of anatomically variable plaque models with clinical anatomical realism. The stability of each plaque was evaluated by finite element analysis (FEA) in which plaque components and vessels were meshed as volumes, modeled as specialized tissues, and subjected to the range of normal coronary blood pressures. To demonstrate the utility of the plaque models, we combined them with the whole-body XCAT computational phantom to perform initial simulations comparing standard energy-integrating detector (EID) CT with photon-counting detector (PCD) CT.

RESULTS

Our results show the network is capable of generating realistic, anatomically variable plaques. Our simulation results provide an initial demonstration of the utility of the generated plaque models as targets to compare different imaging devices.

CONCLUSIONS

Vast, realistic, and variable CAD pathologies can be generated to incorporate into computational phantoms for VITs. There they can serve as a known truth from which to optimize and evaluate cardiac imaging technologies quantitatively.

Quantitative accuracy of lung function measurement using parametric response mapping: A virtual imaging study

Parametric response mapping (PRM) is a voxel-based quantitative CT imaging biomarker that measures the severity of chronic obstructive pulmonary disease (COPD) by analyzing both inspiratory and expiratory CT scans. Although PRM-derived measurements have been shown to predict disease severity and phenotyping, their quantitative accuracy is impacted by the variability of scanner settings and patient conditions. The aim of this study was to evaluate the variability of PRM-based measurements due to the changes in the scanner types and configurations. We developed 10 human chest models with emphysema and air-trapping at end-inspiration and end-expiration states. These models were virtually imaged using a scanner-specific CT simulator (DukeSim) to create CT images at different acquisition settings for energy-integrating and photon-counting CT systems. The CT images were used to estimate PRM maps. The quantified measurements were compared with ground truth values to evaluate the deviations in the measurements. Results showed that PRM measurements varied with scanner type and configurations. The emphysema volume was overestimated by 3 ± 9.5 % (mean ± standard deviation) of the lung volume, and the functional small airway disease (fSAD) volume was underestimated by 7.5±19 % of the lung volume. PRM measurements were more accurate and precise when the acquired settings were photon-counting CT, higher dose, smoother kernel, and larger pixel size. This study demonstrates the development and utility of virtual imaging tools for systematic assessment of a quantitative biomarker accuracy.

Deep silicon photon-counting CT: A first simulation-based study for assessing perceptual benefits across diverse anatomies

OBJECTIVES

To assess perceptual benefits provided by the improved spatial resolution and noise performance of deep silicon photon-counting CT (Si-PCCT) over conventional energy-integrating CT (ECT) using polychromatic images for various clinical tasks and anatomical regions.

MATERIALS AND METHODS

Anthropomorphic, computational models were developed for lungs, liver, inner ear, and head-and-neck (H&N) anatomies. These regions included specific abnormalities such as lesions in the lungs and liver, and calcified plaques in the carotid arteries. The anatomical models were imaged using a scanner-specific CT simulation platform (DukeSim) modeling a Si-PCCT prototype and a conventional ECT system at matched dose levels. The simulated polychromatic projections were reconstructed with matched in-plane resolutions using manufacturer-specific software. The reconstructed pairs of images were scored by radiologists to gauge the task-specific perceptual benefits provided by Si-PCCT compared to ECT based on visualization of anatomical and image quality features. The scores were standardized as z-scores for minimizing inter-observer variability and compared between the systems for evidence of statistically significant improvement (one-sided Wilcoxon rank-sum test with a significance level of 0.05) in perceptual performance for Si-PCCT.

RESULTS

Si-PCCT offered favorable image quality and improved visualization capabilities, leading to mean improvements in task-specific perceptual performance over ECT for most tasks. The improvements for Si-PCCT were statistically significant for the visualization of lung lesion (0.08 ± 0.89 vs. 0.90 ± 0.48), liver lesion (-0.64 ± 0.37 vs. 0.95 ± 0.55), and soft tissue structures (-0.47 ± 0.90 vs. 0.33 ± 1.24) and cochlea (-0.47 ± 0.80 vs. 0.38 ± 0.62) in inner ear.

CONCLUSIONS

Si-PCCT exhibited mean improvements in task-specific perceptual performance over ECT for most clinical tasks considered in this study, with statistically significant improvement for 6/20 tasks. The perceptual performance of Si-PCCT is expected to improve further with availability of spectral information and reconstruction kernels optimized for high resolution provided by smaller pixel size of Si-PCCT. The outcomes of this study indicate the positive potential of Si-PCCT for benefiting routine clinical practice through improved image quality and visualization capabilities.

A systematic assessment of photon-counting CT for bone mineral density and microarchitecture quantifications

Photon-counting CT (PCCT) is an emerging imaging technology with potential improvements in quantification and rendition of micro-structures due to its smaller detector sizes. The aim of this study was to assess the performance of a new PCCT scanner (NAEOTOM Alpha, Siemens) in quantifying clinically relevant bone imaging biomarkers for characterization of common bone diseases. We evaluated the ability of PCCT in quantifying microarchitecture in bones compared to conventional energy-integrating CT. The quantifications were done through virtual imaging trials, using a 50 percentile BMI male virtual patient, with a detailed model of trabecular bone with varied bone densities in the lumbar spine. The virtual patient was imaged using a validated CT simulator (DukeSim) at CTDIvol of 20 and 40 mGy for three scan modes: ultra-high-resolution PCCT (UHR-PCCT), high-resolution PCCT (HR-PCCT), and a conventional energy-integrating CT (EICT) (FORCE, Siemens). Further, each scan mode was reconstructed with varying parameters to evaluate their effect on quantification. Bone mineral density (BMD), trabecular volume to total bone volume (BV/TV), and radiomics texture features were calculated in each vertebra. The most accurate BMD measurements relative to the ground truth were UHR-PCCT images (error: 3.3% ± 1.5%), compared to HR-PCCT (error: 5.3% ± 2.0%) and EICT (error: 7.1% ± 2.0%). UHR-PCCT images outperformed EICT and HR-PCCT. In BV/TV quantifications, UHR-PCCT (errors of 29.7% ± 11.8%) outperformed HR-PCCT (error: 80.6% ± 31.4%) and EICT (error: 67.3% ± 64.3). UHR-PCCT and HR-PCCT texture features were sensitive to anatomical changes using the sharpest kernel. Conversely, the texture radiomics showed no clear trend to reflect the progression of the disease in EICT. This study demonstrated the potential utility of PCCT technology in improved performance of bone quantifications leading to more accurate characterization of bone diseases.

Development and Application of a Virtual Imaging Trial framework for Airway Quantifications via CT

Chronic obstructive pulmonary disease (COPD) is one of the top three causes of death worldwide, characterized by emphysema and bronchitis. Airway measurements reflect the severity of bronchitis and other airway-related diseases. Airway structures can be objectively evaluated with quantitative computed tomography (CT). The accuracy of such quantifications is limited by the spatial resolution and image noise characteristics of the imaging system and can be potentially improved with the emerging photon-counting CT (PCCT) technology. This study evaluated the quantitative performance of PCCT against energy-integrating CT (EICT) systems for airway measurements, and further identified optimum CT imaging parameters for such quantifications. The study was performed using a novel virtual imaging framework by developing the first library of virtual patients with bronchitis. These virtual patients were developed based on CT images of confirmed COPD patients with varied bronchitis severity. The human models were virtually imaged at 6.3 and 12.6 mGy dose levels using a scanner-specific simulator (DukeSim), synthesizing clinical PCCT and EICT scanners (NAEOTOM Alpha, FLASH, Siemens). The projections were reconstructed with two algorithms and kernels at different matrix sizes and slice thicknesses. The CT images were used to quantify clinically relevant airway measurements ("Pi10" and "WA%") and compared against their ground truth values. Compared to EICT, PCCT provided more accurate Pi10 and WA% measurements by 63.1% and 68.2%, respectively. For both technologies, sharper kernels and larger matrix sizes led to more reliable bronchitis quantifications. This study highlights the potential advantages of PCCT against EICT in characterizing bronchitis utilizing a virtual imaging platform.